381 related articles for article (PubMed ID: 2478007)
41. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
Naruse T; Hirokawa N; Oike S; Maekawa T
Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
[TBL] [Abstract][Full Text] [Related]
42. Renal tubular function in children with beta-thalassemia minor.
Kalman S; Atay AA; Sakallioglu O; Ozgürtaş T; Gök F; Kurt I; Kürekçi AE; Ozcan O; Gökçay E
Nephrology (Carlton); 2005 Oct; 10(5):427-9. PubMed ID: 16221088
[TBL] [Abstract][Full Text] [Related]
43. Urinary N-acetyl-beta-glucosaminidase and the selection of children for radiologic evaluation after urinary tract infection.
Johnson CE; Vacca CV; Fattlar D; Fulton DJ; Hall PW
Pediatrics; 1990 Aug; 86(2):211-6. PubMed ID: 2371096
[TBL] [Abstract][Full Text] [Related]
44. [Urinary excretion of N-acetyl-beta-D-glucosaminidase and microglobulin 2 in type I diabetes mellitus].
Sitjar de Togores Alvarez M; Muros de Fuentes M; León López C; García Nieto VM; López Mora E; Rial Rodríguez JM; Rodríguez Rodríguez I; Trujillo Armas R
An Esp Pediatr; 1991 Mar; 34(3):225-9. PubMed ID: 2064152
[TBL] [Abstract][Full Text] [Related]
45. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
[TBL] [Abstract][Full Text] [Related]
46. [Clinical significance of urinary N-acetyl-beta-D-glucosaminidase activities in surgery].
Kamioka T
Nihon Geka Gakkai Zasshi; 1985 Jun; 86(6):657-68. PubMed ID: 4033621
[TBL] [Abstract][Full Text] [Related]
47. Urinary excretion of N-acetyl-beta-D-glucosaminidase in proteinuric states.
Ring E; Zobel G; Erwa W; Haim-Kuttnig M
Child Nephrol Urol; 1992; 12(1):15-8. PubMed ID: 1606575
[TBL] [Abstract][Full Text] [Related]
48. Fever and proximal tubular function in acute pyelonephritis.
Sandberg T; Cooper EH; Lidin-Janson G; Yu H
Nephron; 1985; 41(1):39-44. PubMed ID: 2412142
[TBL] [Abstract][Full Text] [Related]
49. Renal tubular dysfunction in pediatric patients with beta-thalassemia major.
Ahmadzadeh A; Jalali A; Assar S; Khalilian H; Zandian K; Pedram M
Saudi J Kidney Dis Transpl; 2011 May; 22(3):497-500. PubMed ID: 21566307
[TBL] [Abstract][Full Text] [Related]
50. Urinary N-acetyl-beta-D-glucosaminidase and beta 2-microglobulin excretion in primary nephrotic children.
Calişkan S; Hacibekiroğlu M; Sever L; Ozbay G; Arisoy N
Nephron; 1996; 74(2):401-4. PubMed ID: 8893163
[TBL] [Abstract][Full Text] [Related]
51. Kidney- and serum derived proteins in urine of patients suffering from renal diseases or arterial hypertension.
Scherberich JE; Mösbauer A; Meissner A; Bentele D; Schoeppe B; Schoeppe W
Klin Wochenschr; 1989; 67 Suppl 17():44-7. PubMed ID: 2472509
[TBL] [Abstract][Full Text] [Related]
52. Serum beta2-microglobulin in the assessment of renal function.
Bailey RR; Tisch GW; Pearson S
N Z Med J; 1978 Mar; 87(607):168-70. PubMed ID: 77514
[TBL] [Abstract][Full Text] [Related]
53. Application of urinary indicator proteins in the non-invasive assessment of glomerulo-tubular lesions in patients with chronic glomerulonephritis and rheumatoid arthritis.
Weber MH; Verwiebe R; Janning G; Scheler F
Klin Wochenschr; 1989; 67 Suppl 17():48-51. PubMed ID: 2472510
[TBL] [Abstract][Full Text] [Related]
54. Comparative evaluation of four urinary tubular dysfunction markers, with special references to the effects of aging and correction for creatinine concentration.
Moriguchi J; Ezaki T; Tsukahara T; Furuki K; Fukui Y; Okamoto S; Ukai H; Sakurai H; Shimbo S; Ikeda M
Toxicol Lett; 2003 Aug; 143(3):279-90. PubMed ID: 12849688
[TBL] [Abstract][Full Text] [Related]
55. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
Banu N; Hara H; Okamura M; Egusa G; Yamakido M
Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
[TBL] [Abstract][Full Text] [Related]
56. [Alterations in urinary N-Acetyl-beta-D-glucosaminidase (NAG), beta 2-microglobulin (BMG) under acute exposure to simulated 6,000 m altitude].
Sato T; Yamada Y; Hatano Y; Nishikawa E; Fukatsu H; Segawa A; Matsui N
Hinyokika Kiyo; 1985 Apr; 31(4):607-14. PubMed ID: 3898773
[TBL] [Abstract][Full Text] [Related]
57. Urinary beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase (NAG) as early markers of renal tubular dysfunction in sick neonates.
Chen JY; Lee YL; Liu CB
J Formos Med Assoc; 1991 Feb; 90(2):132-7. PubMed ID: 1678405
[TBL] [Abstract][Full Text] [Related]
58. Follow-up of steroid-resistant nephrotic syndrome: tubular proteinuria and enzymuria.
Vallés P; Peralta M; Carrizo L; Martin L; Principi I; Gonzalez A; Manucha W
Pediatr Nephrol; 2000 Dec; 15(3-4):252-8. PubMed ID: 11149121
[TBL] [Abstract][Full Text] [Related]
59. Is the urinary biomarkers assessment a non-invasive approach to tubular lesions of the solitary kidney?
Gadalean F; Kaycsa A; Gluhovschi G; Velciov S; Gluhovschi C; Bob F; Bozdog G; Petrica L
Ren Fail; 2013; 35(10):1358-64. PubMed ID: 23992109
[TBL] [Abstract][Full Text] [Related]
60. Cadmium, NAG activity, and beta 2-microglobulin in the urine of cadmium pigment workers.
Kawada T; Koyama H; Suzuki S
Br J Ind Med; 1989 Jan; 46(1):52-5. PubMed ID: 2645928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
